These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 11095451)
1. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857 [TBL] [Abstract][Full Text] [Related]
3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
4. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India. Dominic N; Sharma L; Mohindra N; Dabadghao P Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813 [TBL] [Abstract][Full Text] [Related]
6. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641 [TBL] [Abstract][Full Text] [Related]
7. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477 [TBL] [Abstract][Full Text] [Related]
8. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism. Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185 [TBL] [Abstract][Full Text] [Related]
9. Polycystic ovaries in Hirsute women with normal menses. Carmina E; Lobo RA Am J Med; 2001 Dec; 111(8):602-6. PubMed ID: 11755502 [TBL] [Abstract][Full Text] [Related]
10. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Asunción M; Calvo RM; San Millán JL; Sancho J; Avila S; Escobar-Morreale HF J Clin Endocrinol Metab; 2000 Jul; 85(7):2434-8. PubMed ID: 10902790 [TBL] [Abstract][Full Text] [Related]
12. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes. García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome. Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Vosnakis C; Katsikis I Eur J Endocrinol; 2013 Jun; 168(6):871-7. PubMed ID: 23557988 [TBL] [Abstract][Full Text] [Related]
15. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298 [TBL] [Abstract][Full Text] [Related]
16. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. Codner E; Escobar-Morreale HF J Clin Endocrinol Metab; 2007 Apr; 92(4):1209-16. PubMed ID: 17284617 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706 [TBL] [Abstract][Full Text] [Related]
18. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy. Zachurzok A; Deja G; Gawlik A; Drosdzol-Cop A; Małecka-Tendera E Endokrynol Pol; 2013; 64(2):121-8. PubMed ID: 23653275 [TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418 [TBL] [Abstract][Full Text] [Related]
20. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Roldán B; Escobar-Morreale HF; Barrio R; de La Calle H; Alonso M; García-Robles R; Sancho J Diabetes Care; 2001 Jul; 24(7):1297-9. PubMed ID: 11423519 [No Abstract] [Full Text] [Related] [Next] [New Search]